Comparative analysis of the differences in ingredients and therapeutic effects between F/TAF and Sufatai

Dacova (F/TAF, full name is tenofovir disoproxil fumarate/emtricitabine tablets) and Shufatai (F/TDF, the full name of tenofovir disoproxil fumarate/emtricitabine tablets) are antiHIV compound oral drugs, the main ingredients are emtricitabine (Emtricitabine, FTC) combined with tenofovir prodrug. The difference between the two is the prodrug form of tenofovir: Tenofovir disoproxil fumarate (Tenofovir disoproxil fumarate). This difference in chemical structure affects the metabolism and distribution of drugs in the body.

TAFIt is easier to enter lymphocytes in the body and is directly converted into the active substance tenofovir diphosphate fumarate. The concentration of tenofovir diphosphate in plasma is low, so it is less toxic to the kidneys and bones. TDF is mostly converted into active substances in plasma, and long-term use may lead to renal function damage and decreased bone density. Therefore, TAF preparations have obvious safety advantages and are especially suitable for patients with kidney or bone risks.

In clinical trials, F/TAF and F/TDF were effective in inhibiting HIVThe efficacy is similar in terms of viral replication. Both can reduce the viral load to undetectable levels in most patients within 24 to 48 weeks. Research shows that F/TAF is consistent with F/TDF in maintaining viral suppression during long-term treatment, but is superior to F/TDF in terms of renal function and bone density protection, and is more suitable for patients who require long-term treatment.

BecauseF/TAFthe plasma concentration of tenofovir is low, and the risk of damage to renal tubules and bones is small, which can reduce the risk of chronic kidney disease and osteoporosis. F/TDFRenal function and bone density need to be monitored regularly, especially in elderly patients or those with chronic kidney disease. Both are oral once-a-day medications and must be strictly followed as prescribed by the doctor. Do not increase or decrease the dose or stop the medication on your own to ensure antiviral efficacy and drug resistance risk control. Generally speaking, F/TAF has more advantages in terms of safety, and the two are basically equivalent in terms of antiviral efficacy.

Reference link:https://www.drugs.com